anonymous
Guest
anonymous
Guest
Long acting insulin package inserts have few warnings and contractions. It makes sense to give a defective pancreas a rest with long acting insulin and cells need energy anyway. It makes absolutely no since for long acting laboratory GLP1 to unnaturally signal insulin production and storage in healthly pancreas when people are eating less to achieve weight loss. The insulin release from the pancreas is “Glucose Dependent” and happens less because people are eating less. Normally when people do not eat, less insulin is produced and stored. Your package insert lists pancreatitis. Also, the National Institutes of health urgently wants to study Thyroid Tumors with your product as well. What else are they going to find? The lawyers are doing to have a field day. The executive have cashed their stock options and drink cocktails under beach umbrellas and join tennis country clubs while employees loose jobs and pension is reduced. This is crazy!!!